Skip to main content
. 2014 Aug 30;2014(48):115–124. doi: 10.1093/jncimonographs/lgu004

Table 1.

Descriptive characteristics of hairy cell leukemia cases and controls

Controls, N (%) Cases, N (%)
Total 8834 (98.3) 154 (1.7)
Study
 Europe
 Engela 722 (8.2) 36 (23.4)
 EpiLymph 2460 (27.8) 15 (9.7)
 Italy multicenter 1771 (20.0) 30 (19.5)
 SCALE 3187 (36.1) 63 (40.9)
 Australia
 New South Wales 694 (7.9) 10 (6.5)
Region
 North America 0 (0.0) 0 (0.0)
 Northern Europe 5403 (61.2) 112 (72.7)
 Southern Europe 2737 (31.0) 32 (20.8)
 Australia 694 (7.9) 10 (6.5)
Design
 Population-based 6698 (75.8) 109 (70.8)
 Hospital-based 2136 (24.2) 45 (29.2)
Age
 <30 640 (7.2) 1 (0.6)
 30–39 750 (8.5) 14 (9.1)
 40–49 1241 (14.0) 38 (24.7)
 50–59 2072 (23.5) 48 (31.2)
 60–69 2614 (29.6) 43 (27.9)
 70–79 1454 (16.5) 10 (6.5)
 ≥80 63 (0.7) 0 (0.0)
Sex
 Male 4840 (54.8) 121 (78.6)
 Female 3994 (45.2) 33 (21.4)
Race
 White, non-Hispanic 8501 (96.2) 148 (96.1)
 Black 2 (0.0) 0 (0.0)
 Asian 14 (0.2) 0 (0.0)
 Hispanic 0 (0.0) 0 (0.0)
 Other or unknown or missing 317 (3.6) 6 (3.9)
Socioeconomic status
 Low 3446 (39.0) 47 (30.5)
 Medium 3015 (34.1) 39 (25.3)
 High 2320 (26.3) 67 (43.5)
 Other or missing 53 (0.6) 1 (0.6)
Non-Hodgkin lymphoma classification
 World Health Organization 7063 (80.0) 124 (80.5)
 Working Formulation 1771 (20.0) 30 (19.5)